Renaissance Technologies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.3M | Buy |
|
|||||
|
2025
Q1 | $63.3M | Buy |
|
|||||
|
2024
Q4 | $28.6M | Buy |
|
|||||
|
2024
Q3 | $29.4M | Buy |
|
|||||
|
2024
Q2 | $9.57M | Sell |
|
|||||
|
2024
Q1 | $47.3M | Buy |
|
|||||
|
2023
Q4 | $37.3M | Sell |
|
|||||
|
2023
Q3 | $51.5M | Sell |
|
|||||
|
2023
Q2 | $63.5M | Sell |
|
|||||
|
2023
Q1 | $76M | Buy |
|
|||||
|
2022
Q4 | $65.2M | Sell |
|
|||||
|
2022
Q3 | $63.1M | Buy |
|
|||||
|
2022
Q2 | $60.9M | Buy |
|
|||||
|
2022
Q1 | $37.9M | Sell |
|
|||||
|
2021
Q4 | $57.5M | Buy |
|
|||||
|
2021
Q3 | $29.5M | Buy |
|
|||||
|
2021
Q2 | $24.2M | Sell |
|
|||||
|
2021
Q1 | $27.6M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.61M | Sell |
|
|||||
|
2019
Q4 | $17.1M | Sell |
|
|||||
|
2019
Q3 | $37.5M | Buy |
|
|||||
|
2019
Q2 | $46M | Buy |
|
|||||
|
2019
Q1 | $28.6M | Buy |
|
|||||
|
2018
Q4 | $3.71M | Sell |
|
|||||
|
2018
Q3 | $20.1M | Buy |
|
|||||
|
2018
Q2 | $2.68M | Sell |
|
|||||
|
2018
Q1 | $10.4M | Sell |
|
|||||
|
2017
Q4 | $23.3M | Sell |
|
|||||
|
2017
Q3 | $29.8M | Buy |
|
|||||
|
2017
Q2 | $11.5M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $3.26M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10.9M | Sell |
|
|||||
|
2015
Q4 | $20.3M | Sell |
|
|||||
|
2015
Q3 | $27.7M | Buy |
|
|||||
|
2015
Q2 | $16.9M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $19.7M | Buy |
|